You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Burosumab

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

X-linked Hypophosphatemia, Tumor-Induced Osteomalacia Trial (Burosumab)

Available
  • X-linked Hypophosphatemia
  • Tumor-Induced Osteomalacia
  • Burosumab
  • (no location specified)
Nov 22, 2022

X-linked Hypophosphatemia Trial in New Haven (Burosumab Injection [Crysvita])

Completed
  • X-linked Hypophosphatemia
  • Burosumab Injection [Crysvita]
  • New Haven, Connecticut
    Yale University School of Medicine
Oct 7, 2022

Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)

Not yet recruiting
  • Fibrous Dysplasia Of Bone
  • Burosumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts

Completed
  • Hypophosphatemic Rickets
  • blood sample
  • Bron, France
  • +2 more
Oct 5, 2022

X-linked Hypophosphatemia Trial in Würzburg (Burosumab)

Active, not recruiting
  • X-linked Hypophosphatemia
  • Burosumab
  • Würzburg, Germany
    Clinical Trial Unit, Orthopedic Department, Wuerzburg University
Apr 26, 2022

Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS), Epidermal Nevus Syndrome Trial in Washington (Burosumab)

Active, not recruiting
  • Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
  • Epidermal Nevus Syndrome
  • Burosumab
  • Washington, District of Columbia
    Children's National Hospital
Mar 4, 2022

X-linked Hypophosphatemia (XLH) Trial in Worldwide (Burosumab)

Active, not recruiting
  • X-linked Hypophosphatemia (XLH)
  • Burosumab
  • Linz, Austria
  • +8 more
Oct 4, 2022

Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts

Recruiting
  • Craniosynostoses
  • osteoblast biology study
  • Bron, France
    Centre de référence des craniosténoses et malformations cranio-f
Mar 22, 2022

Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS) Trial in United States (Burosumab)

Completed
Has Results
  • Tumor Induced Osteomalacia (TIO)
  • Epidermal Nevus Syndrome (ENS)
  • Burosumab
  • Golden, Colorado
  • +6 more
Jan 20, 2022

Tumor-Induced Osteomalacia (TIO) Trial in Beijing, Chengdu, Shanghai (KRN23)

Recruiting
  • Tumor-Induced Osteomalacia (TIO)
  • Beijing, China
  • +2 more
Sep 10, 2022

X-Linked Hypophosphatemia Trial in France, Netherlands, United Kingdom (Burosumab)

Recruiting
  • X-Linked Hypophosphatemia
  • Burosumab
  • Lille, France
  • +7 more
Jan 14, 2022

X-linked Hypophosphatemia (XLH) Trial in Beijing, Guangzhou, Shanghai (KRN23)

Recruiting
  • X-linked Hypophosphatemia (XLH)
  • Beijing, China
  • +2 more
Nov 10, 2021

X-linked Hypophosphatemia (XLH) Trial in China (KRN23)

Recruiting
  • X-linked Hypophosphatemia (XLH)
  • Beijing, China
  • +4 more
Nov 10, 2021

Rare Diseases, X-linked Hypophosphatemia Trial in Le Kremlin-Bicêtre (Burosumab Injection)

Recruiting
  • Rare Diseases
  • X-linked Hypophosphatemia
  • Burosumab Injection
  • Le Kremlin-Bicêtre, France
    Hospital Bicetre
Jun 3, 2020

X-linked Hypophosphatemia Disease Monitoring Program

Active, not recruiting
  • X-linked Hypophosphatemia
  • Hypophosphatemic Rickets
  • No intervention
  • Birmingham, Alabama
  • +38 more
Dec 7, 2022

Tumor-induced Osteomalacia Disease Monitoring Program

Recruiting
  • Tumor-induced Osteomalacia (TIO)
  • No intervention
  • New Haven, Connecticut
  • +3 more
Jul 29, 2022

Hypophosphatemia, Hypophosphatemic Rickets, Pain, Chronic Trial in Clinton (Burosumab)

Completed
  • Hypophosphatemia
  • +2 more
  • Burosumab
  • Clinton, Utah
    The Focus Center, PC
Jan 14, 2020

X-linked Hypophosphatemia Trial in Worldwide (burosumab, Placebo)

Completed
Has Results
  • X-linked Hypophosphatemia
  • burosumab
  • Placebo
  • Los Angeles, California
  • +24 more
Jan 15, 2021

X-Linked Hypophosphataemia Trial in United Kingdom

Recruiting
  • X-Linked Hypophosphataemia
    • Glasgow, United Kingdom
    • +3 more
    Aug 30, 2022

    X-Linked Hypophosphatemia Trial in Worldwide (burosumab, Oral Phosphate Supplement, active vitamin D)

    Completed
    Has Results
    • X-Linked Hypophosphatemia
    • burosumab
    • +2 more
    • Los Angeles, California
    • +15 more
    Jan 12, 2020

    X-Linked Hypophosphatemia Trial in New Haven, Indianapolis, Saint Louis (Burosumab)

    Completed
    Has Results
    • X-Linked Hypophosphatemia
    • Burosumab
    • New Haven, Connecticut
    • +2 more
    Mar 20, 2020

    X-linked Hypophosphatemia Trial in Worldwide (burosumab)

    Completed
    Has Results
    • X-linked Hypophosphatemia
    • burosumab
    • San Francisco, California
    • +8 more
    Jul 8, 2019

    X-Linked Hypophosphatemia Trial in United States (KRN23)

    Completed
    Has Results
    • X-Linked Hypophosphatemia
    • KRN23
    • San Francisco, California
    • +4 more
    Nov 26, 2019

    X-linked Hypophosphatemia Trial in Worldwide (burosumab)

    Completed
    Has Results
    • X-linked Hypophosphatemia
    • burosumab
    • San Francisco, California
    • +13 more
    Dec 12, 2019

    X-Linked Hypophosphatemia Trial in Worldwide

    Recruiting
    • X-Linked Hypophosphatemia
      • Brussel, Belgium
      • +115 more
      Mar 29, 2022